PL2640364T3 - Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych - Google Patents
Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnychInfo
- Publication number
- PL2640364T3 PL2640364T3 PL11796758T PL11796758T PL2640364T3 PL 2640364 T3 PL2640364 T3 PL 2640364T3 PL 11796758 T PL11796758 T PL 11796758T PL 11796758 T PL11796758 T PL 11796758T PL 2640364 T3 PL2640364 T3 PL 2640364T3
- Authority
- PL
- Poland
- Prior art keywords
- medicament
- prevention
- treatment
- pharmaceutical composition
- related diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1059472A FR2967577B1 (fr) | 2010-11-18 | 2010-11-18 | Composition pharmaceutique comprenant du sel de bicarbonate, et son utilisation comme medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2640364T3 true PL2640364T3 (pl) | 2017-09-29 |
Family
ID=44168791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11796758T PL2640364T3 (pl) | 2010-11-18 | 2011-11-18 | Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych |
Country Status (9)
Country | Link |
---|---|
US (1) | US9662296B2 (pl) |
EP (1) | EP2640364B9 (pl) |
JP (1) | JP5879358B2 (pl) |
DK (1) | DK2640364T3 (pl) |
ES (1) | ES2622503T3 (pl) |
FR (1) | FR2967577B1 (pl) |
HU (1) | HUE032753T2 (pl) |
PL (1) | PL2640364T3 (pl) |
WO (1) | WO2012066256A1 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434457A (zh) * | 2014-09-23 | 2016-03-30 | 中山未标生物新技术有限公司 | 一种用于防治消化道癌性病变的肠溶口服制剂及其制备方法和其应用 |
JP6213591B2 (ja) | 2016-02-25 | 2017-10-18 | 第一精工株式会社 | コネクタ |
CN112203686A (zh) * | 2018-05-25 | 2021-01-08 | 国立大学法人琉球大学 | 代谢改善剂 |
CN111228239B (zh) * | 2020-01-13 | 2022-04-22 | 厦门金达威生物科技有限公司 | 一种pH敏感型凝胶微胶囊及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451454A (en) | 1981-06-16 | 1984-05-29 | Wong Dennis W | Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals |
GB2130087A (en) | 1982-09-22 | 1984-05-31 | Dr Joachime Helbig | Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions |
IE80467B1 (en) * | 1995-07-03 | 1998-07-29 | Elan Corp Plc | Controlled release formulations for poorly soluble drugs |
EP1970066A1 (de) * | 2007-03-12 | 2008-09-17 | Medice Arzneimittel Pütter GmbH & Co. KG | Pharmazeutische Zusammensetzung zur Behandlung einer Übersäuerung des Blutes |
WO2009118359A2 (en) * | 2008-03-28 | 2009-10-01 | Ferrer Internacional S.A. | Capsule for the prevention of cardiovascular diseases |
WO2009140341A2 (en) * | 2008-05-13 | 2009-11-19 | Dr. Reddy's Laboratories Ltd. | Atorvastatin compositions |
-
2010
- 2010-11-18 FR FR1059472A patent/FR2967577B1/fr active Active
-
2011
- 2011-11-18 PL PL11796758T patent/PL2640364T3/pl unknown
- 2011-11-18 ES ES11796758.8T patent/ES2622503T3/es active Active
- 2011-11-18 US US13/988,025 patent/US9662296B2/en active Active
- 2011-11-18 JP JP2013539317A patent/JP5879358B2/ja active Active
- 2011-11-18 HU HUE11796758A patent/HUE032753T2/en unknown
- 2011-11-18 DK DK11796758.8T patent/DK2640364T3/en active
- 2011-11-18 EP EP11796758.8A patent/EP2640364B9/fr active Active
- 2011-11-18 WO PCT/FR2011/052695 patent/WO2012066256A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012066256A1 (fr) | 2012-05-24 |
FR2967577B1 (fr) | 2013-07-12 |
DK2640364T3 (en) | 2017-05-01 |
EP2640364B9 (fr) | 2017-08-30 |
FR2967577A1 (fr) | 2012-05-25 |
US9662296B2 (en) | 2017-05-30 |
JP5879358B2 (ja) | 2016-03-08 |
EP2640364B1 (fr) | 2017-01-18 |
HUE032753T2 (en) | 2017-10-30 |
US20130230590A1 (en) | 2013-09-05 |
ES2622503T3 (es) | 2017-07-06 |
EP2640364A1 (fr) | 2013-09-25 |
JP2013542974A (ja) | 2013-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL223783B (en) | Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine | |
ZA201304638B (en) | Composition for use in the prevention and /or treatment of skin condition and skin diseases. | |
IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
EP1985302A4 (en) | DRUGS FOR TUMOR THERAPY AND ITS USE | |
IL210589A (en) | C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB | |
IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
IL206080A0 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
ZA201209289B (en) | Urea derivatives and their therapeutic use in the treatment of,inter alia,diseases of the respiratory tract | |
IL217901B (en) | Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases | |
IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
IL232325A0 (en) | 18-methyl-7,6-methylene-3-oxo-17-paragan-4-en-21, 17b-carbolactones, pharmaceutical preparations containing these compounds and their use for the treatment of endometrial disease | |
EP2528603A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS | |
ZA201104011B (en) | Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases | |
GB2503066B8 (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
IL251543A0 (en) | Use of gel compounds in the production of medicine to prevent or treat skin diseases | |
IL200278A (en) | Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness | |
ZA201203281B (en) | Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals | |
IL218277B (en) | Tetracycline compounds, pharmaceutical preparations containing them and their use for the preparation of medicines for the treatment and prevention of infection | |
GB201303868D0 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
IL194880A (en) | Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them | |
HK1168283A1 (zh) | 類的試劑在治療抗胰島素和相關疾病的用途 | |
EP2231148A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE | |
PL2640364T3 (pl) | Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych | |
IL217519A (en) | Derivatives of tazarotene, pharmaceutical preparations containing them and their use in the preparation of medicines for the treatment of skin diseases | |
PT2603238E (pt) | Métodos e composições farmacêuticas para o tratamento de uma doença ocular num indíviduo |